| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/27/2006 | EP1735006A1 Polymer particles containing active agents |
| 12/27/2006 | EP1735005A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability |
| 12/27/2006 | EP1735004A1 Dietary supplement and method of processing same |
| 12/27/2006 | EP1734994A1 Site-specific chemical modification of hiv gp41-derived peptides |
| 12/27/2006 | EP1734993A2 Apparatus and method for transdermal delivery of influenza vaccine |
| 12/27/2006 | EP1734988A2 Interferon-beta polymer conjugates |
| 12/27/2006 | EP1734984A2 Compositions and methods for topical diagnostic and therapeutic transport |
| 12/27/2006 | EP1734936A2 Amphiphilic star-like or scoprion-like macromolecules, various compositions and uses thereof |
| 12/27/2006 | EP1734935A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 12/27/2006 | EP1734932A1 Pharmaceutical compositions comprising an amphiphilic starch |
| 12/27/2006 | EP1734927A1 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides |
| 12/27/2006 | EP1734926A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 12/27/2006 | EP1734925A2 Novel compositions for topical delivery |
| 12/27/2006 | EP1734923A1 Zinc preservative composition and method of use |
| 12/27/2006 | EP1734819A1 Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers |
| 12/27/2006 | EP1675620A4 Polymer derivatives |
| 12/27/2006 | EP1653963B1 Nasal pharmaceutical piribedil composition |
| 12/27/2006 | EP1575551A4 Nutritional supplement composition and method |
| 12/27/2006 | EP1534682B1 Novel molecules derived from noraporphine |
| 12/27/2006 | EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 12/27/2006 | EP1363730B1 Process for making microcapsules involving phase inversion |
| 12/27/2006 | EP1335710B1 Soft capsules comprising a starch mixture having a reduced branching degree |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 12/27/2006 | EP1231898B1 Apparatus and method for preparing microparticles |
| 12/27/2006 | EP1216028B1 Biodegradable excipient systems for therapeutically active substances and method for producing the same |
| 12/27/2006 | EP1187806B1 Spermine:peptide-based surfactant compounds |
| 12/27/2006 | EP1185618B1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 12/27/2006 | EP1165100B1 Methods of treating schizophrenia |
| 12/27/2006 | EP1083885B1 Delavirdine tablet formulation |
| 12/27/2006 | EP1007549B1 Compositions and methods for highly efficient transfection |
| 12/27/2006 | EP1007011B1 Lock and key micelles |
| 12/27/2006 | CN1886500A Phosphokinase and the usage thereof |
| 12/27/2006 | CN1886427A Cellulose interpolymers and method of oxidation |
| 12/27/2006 | CN1886171A Method and system for rapid transdermal administration |
| 12/27/2006 | CN1886158A Pharmaceutical preparation comprising an antibody against the EGF receptor |
| 12/27/2006 | CN1886154A Clostridium botulinum C3 exotransferase compositions and methods for treating tumour spreading |
| 12/27/2006 | CN1886153A Excipients in drug delivery vehicles |
| 12/27/2006 | CN1886152A Minimization of drug oxidation in drug irradiated excipients formulations |
| 12/27/2006 | CN1886151A Pharmaceutical formulations for the sustained release of oneor more active principles and applications thereof, such as therapeutic applications |
| 12/27/2006 | CN1886139A Soft steroid compositions for use in dry powder inhalers |
| 12/27/2006 | CN1886128A Compositions and methods for treating burns |
| 12/27/2006 | CN1886119A Pantoprazole multiparticulate formulations |
| 12/27/2006 | CN1886105A Enhancing transdermal administration of hydrophilic drugs |
| 12/27/2006 | CN1883710A Chemical modification method of antineoplastic oligopeptide and application thereof |
| 12/27/2006 | CN1883709A Bi-functional targeting antineoplastic polypeptide and application thereof |
| 12/27/2006 | CN1883708A Surface-modified hydrophobically modified drug-carried chitosan polymer micelle and method for preparing same |
| 12/27/2006 | CN1883707A Lyophilized preparation of recombinant adenovirus and preparation method thereof |
| 12/27/2006 | CN1883701A Ciliary nerves nutrilite composition having long-time stability |
| 12/27/2006 | CN1883620A Gel agent for treating superficial mycotic infection and method for preparing same |
| 12/27/2006 | CN1883532A Drop pills for treating coronary heart disease and angina pectoris and preparation method thereof |
| 12/27/2006 | CN1883504A Medium and method for preserving platelets, red blood cells, and other non-nucleus cells and platelets-containing composition |
| 12/27/2006 | CN1883497A Ginsenoside Rh2 hydroxypropyl-beta-cyclodextrin inclusion compound and preparation method thereof |
| 12/27/2006 | CN1883488A Preparation method of minocycline hydrochloride chitosan microsphere and application thereof |
| 12/27/2006 | CN1883485A A gel for treating chronic cutaneous pruritus and preparation method thereof |
| 12/27/2006 | CN1883472A Orally disintegrating tablet of ginkgolide and preparation method thereof |
| 12/27/2006 | CN1883465A Apoferritin ¿Cplatinum anticancer drug composition and preparation method thereof |
| 12/27/2006 | CN1883462A Nicotine transdermal delivery system |
| 12/27/2006 | CN1883461A Sustained-releasing oral mucosa medicinal film |
| 12/27/2006 | CN1883460A An enteric coated mini-pill of pantoprazole sodium |
| 12/27/2006 | CN1883459A Enteric coated preparation of entecavir and preparation method thereof |
| 12/27/2006 | CN1883458A Enteric coated preparation of lansoprazole sodium and preparation method thereof |
| 12/27/2006 | CN1883457A Lyophilized suspended powder injection and preparation method thereof |
| 12/27/2006 | CN1883456A Flavor-hidden pharmaceutical granule, preparation method and use thereof |
| 12/27/2006 | CN1883455A A long-circulating nanoliposome carrier of hydroxycamptothecine and preparation method thereof |
| 12/27/2006 | CN1883454A Liposome administration system with tumor necrosis targeted antibody for preposition and application thereof |
| 12/27/2006 | CN1883453A An angiogenesis inhibitor and synergist thereof co-carried sustained-releasing anticancer medicinal injection |
| 12/27/2006 | CN1883452A An angiogenesis inhibitor and synergist thererof co-carried sustained-release anticancer agent |
| 12/27/2006 | CN1883451A A sustained-release anticancer injection containing angiogenesis inhibitor and synergist thereof |
| 12/27/2006 | CN1883450A A hydrophilic gel plaster substrate |
| 12/27/2006 | CN1292038C Hydrophilic polyurethane pressure-sensitive adhesive and preparing method thereof |
| 12/27/2006 | CN1291758C Coupling agent of CB and specific immune globulin IgG and medical use thereof |
| 12/27/2006 | CN1291755C Pharmaceutical compositions capable of enhancing the immunogenicity of poorly immunogenic antigens |
| 12/27/2006 | CN1291719C Solid dispersion composition |
| 12/27/2006 | CN1291713C Novel composition with taxane as major component |
| 12/27/2006 | CN1291703C Method and apparatus for improved administration of pharmaceutically active compounds |
| 12/26/2006 | US7154001 Formate salt of O-desmethyl-venlafaxine |
| 12/26/2006 | US7153977 Ligands and methods for preparing same |
| 12/26/2006 | US7153946 Molecular conjugates for use in treatment of cancer |
| 12/26/2006 | US7153932 Immunotoxins comprising ribosome-inactivating proteins |
| 12/26/2006 | US7153931 Forms of membrane transport vector penetratin; a membrane translocation peptide carrier moiety of given amino acid sequence; use in the improved delivery of therapeutic agents into target cells |
| 12/26/2006 | US7153864 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 12/26/2006 | US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis |
| 12/26/2006 | US7153840 Aqueous fludarabine phosphate composition |
| 12/26/2006 | US7153838 Pharmacologically acceptable solvent vehicles |
| 12/26/2006 | US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
| 12/26/2006 | US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes |
| 12/26/2006 | US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
| 12/26/2006 | US7153572 Porous beads and method of production thereof |
| 12/26/2006 | US7153526 Diagnosing bacteria infections; administering aqueou solution of silver colloids |
| 12/26/2006 | US7153524 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal |
| 12/26/2006 | US7153522 bases comprising isoprene-styrene block copolymer and/or polyisobutylene, softeners and tackifier resins, hexylene glycol and 1-menthol as skin absorption intensifiers, and hormones as the drug components |
| 12/26/2006 | US7153520 Composition for sustained delivery of hydrophobic drugs and process for the preparation thereof |
| 12/26/2006 | US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 12/26/2006 | US7153497 Exhibiting constant release rate and delayed release profiles |
| 12/26/2006 | US7153492 prophylactic or wound-healing treatment of lactating animals prone to develop or suffering from mastitis; chitosan, its derivatives and salts thereof and a second component capable of releasing CO2 in an acidic environment |
| 12/26/2006 | US7153490 Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumors |
| 12/21/2006 | WO2006135930A2 Transmucosal delivery of peptide derivatives |
| 12/21/2006 | WO2006135775A2 Rapid saccharide biomarker assay |
| 12/21/2006 | WO2006135506A2 Compositions for topical enzymatic debridement |